Harm Reduction Therapeutics
  • Our Story
  • OTC RiVive®
  • Why 3 mg?
  • Contact Us
  • Login
  • My Account
  • Buy Now
  • What Is Harm Reduction
  • Resources
  • News
  • FAQ
  • What Is Harm Reduction?
  • Resources
  • News
  • FAQ
2024 RiVive Community Feedback Report

2024 RiVive Community Feedback Report

by C Tetro | Apr 7, 2025 | News

Harm Reduction Therapeutics Marks International Overdose Awareness Day with Free Donations of RiVive® Life-Saving Over-the-Counter Naloxone Nasal Spray

Harm Reduction Therapeutics Marks International Overdose Awareness Day with Free Donations of RiVive® Life-Saving Over-the-Counter Naloxone Nasal Spray

by Jim Kelly | Sep 3, 2024 | News

Compassionate Overdose Response Summit Highlights and Key Takeaways

Compassionate Overdose Response Summit Highlights and Key Takeaways

by Maria Keddis | Aug 27, 2024 | News

A2A Alliance Pharmaceuticals and Harm Reduction Therapeutics Announce Strategic Partnership to Expand Access to Life-Saving OTC Naloxone 3mg Nasal Spray (RiVive™) to U.S. Federal Entities and Veterans

A2A Alliance Pharmaceuticals and Harm Reduction Therapeutics Announce Strategic Partnership to Expand Access to Life-Saving OTC Naloxone 3mg Nasal Spray (RiVive™) to U.S. Federal Entities and Veterans

by Jim Kelly | Aug 14, 2024 | News

Statement Regarding High Dose Naloxone and Long Acting Nalmefene Opioid Overdose Reversal Formulations

Statement Regarding High Dose Naloxone and Long Acting Nalmefene Opioid Overdose Reversal Formulations

by Maria Keddis | Jul 29, 2024 | News

Exploring Cost and the Emerging Landscape of Naloxone Competition

Exploring Cost and the Emerging Landscape of Naloxone Competition

by Maria Keddis | Jul 22, 2024 | News

« Older Entries
  • Contact Us
  • Privacy Policy
  • Accessibility
  • FAQ
  • Follow
  • Follow

© Copyright 2025 Harm Reduction Therapeutics, Inc. All Rights Reserved. To report Adverse Events contact: customercare@harmreductiontherapeutics.org.